Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalat...

Source: Journal of Hematology and Oncology - July 22, 2023 Category: Hematology Authors: Maria-Luisa Schubert, Anita Schmitt, Angela H ückelhoven-Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp-Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick De Tags: Research Source Type: research